Impact of an Early Warning System on the Prognosis of Patients With Hematological Malignancies Receiving Intensive Chemotherapy With or Without Hematopoietic Cell Transplantation. — Stella
Impact of an Early Warning System on the Prognosis of Patients With Hematological Malignancies Receiving Intensive Chemotherapy With or Without Hematopoietic Cell Transplantation.
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations(10 sites)
France
Centre Hospitalier Amiens-Picardie, Amiens
Centre Hospitalier Universitaire d'Angers, Angers
Centre Hospitalier Universitaire Besancon, Besançon
Centre Hospitalier Universitaire Brest, Brest
Centre Hospitalier universitaire Nancy, Nancy
Centre Hospitalier Universitaire Nantes, Nantes
Centre Hospitalier Universitaire poitiers, Poitiers
centre Hospitalier Universitaire Saint etienne, Saint-Etienne
centre Hospitalier Universitaire Strasbourg, Strasbourg